Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-09

Clinical Trial Update: Breast Cancer Active Surveillance, Alternative Option, Aspirin Included [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a phase 2/3 breast cancer study examining active surveillance with an aspirin-containing option; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Centro Hospitalar Lisboa Ocidental | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN